Here are four things to know:
1. Mr. Turkaly set a $22 price target on K2M shares.
2. Last Friday, K2M shares closed at $13.81.
3. Analysts have a consensus rating of “strong buy” on K2M shares. Their average price target is $21.50.
4. On May 23, Needham analysts increased K2M’s rating to “buy,” and set a $21 price target.
More articles on devices:
Medtronic, K2M, J&J & more: 15 key notes
3 emerging trends that could impact the global spinal implants market
Global SCS market to grow to 2028: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
